Abiopharma

Clinical trial NCT04940052: completion date: 2027-05-17 → 2027-05-25.

Clinical trial NCT04122976 updates: 1. completion date: 2026-12-30 → 2026-10-07 2. primary completion date: 2026-12-30 → 2026-07-07

Clinical trial NCT07470866 updates: 1. status: RECRUITING → TERMINATED 2. primary completion date: 2026-06-02 → 2026-05-12 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05913687 updates: 1. completion date: 2026-03-31 → 2027-03-31 2. primary completion date: 2026-03-31 → 2027-03-31

Clinical trial NCT06366451 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-04-01 → 2026-03-25 3. primary completion date: 2025-02-01 → 2026-03-25 4. enrollment: 15 → 17 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07433322: start date: 2026-05-01 → 2026-06-01.

Clinical trial NCT05255601: status: COMPLETED → TERMINATED.

Clinical trial NCT07416162 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-31 → 2026-06-15

Clinical trial NCT07602582 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-22 3. completion date: 2029-12-01 → 2029-09-01

Clinical trial NCT07088458: start date: 2026-06-18 → 2026-06-30.